Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection

Clinical trial NCT01779271 · COMPLETED

Trial details

NCT number: NCT01779271
Sponsor: Daewon Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Upper Respiratory Infection Fever

Start date: 2013-01-01
Primary completion: 2016-03-01
Enrollment: 183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.